Burning Rock Biotech (BNR) Total Non-Current Liabilities (2021 - 2023)

Burning Rock Biotech has reported Total Non-Current Liabilities over the past 3 years, most recently at $1.1 million for Q4 2023.

  • Quarterly results put Total Non-Current Liabilities at $1.1 million for Q4 2023, down 54.02% from a year ago — trailing twelve months through Dec 2023 was $1.1 million (down 54.02% YoY), and the annual figure for FY2023 was $1.2 million, down 56.01%.
  • Total Non-Current Liabilities for Q4 2023 was $1.1 million at Burning Rock Biotech, down from $2.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BNR hit a ceiling of $9.6 million in Q4 2021 and a floor of $1.1 million in Q4 2023.
  • Median Total Non-Current Liabilities over the past 3 years was $2.5 million (2022), compared with a mean of $4.4 million.
  • Biggest five-year swings in Total Non-Current Liabilities: crashed 73.99% in 2022 and later plummeted 54.02% in 2023.
  • Burning Rock Biotech's Total Non-Current Liabilities stood at $9.6 million in 2021, then crashed by 73.99% to $2.5 million in 2022, then plummeted by 54.02% to $1.1 million in 2023.
  • The last three reported values for Total Non-Current Liabilities were $1.1 million (Q4 2023), $2.5 million (Q4 2022), and $9.6 million (Q4 2021) per Business Quant data.